Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-05

FDA Approved: MESALAMINE — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved the original ANDA for mesalamine submitted by NorthStar RxLLC, a generic formulation intended for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)